Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. in Glycemic Control of Diabetic Patients

This study has been completed.
Sponsor:
Information provided by:
Zanjan University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01228240
First received: October 25, 2010
Last updated: NA
Last verified: November 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)